Hypertension, Cardiovascular Risk
touchEXPERT OPINIONS
Medical therapy for CTEPH: From biology to new treatment options
CME ACCREDITED
Prof. Irene Lang (Austria), Prof. Marc Humbert (France), Dr Mark Toshner (UK)
Watch Time: 30 mins
Watch leading experts involved in the care of patients with CTEPH discuss the latest issues and controversies in the medical management of CTEPH and related comorbidities, including the evolving data supporting the use of oral therapy, the application of oral therapies in clinical practice and how the underlying biology impacts on treatment decisions.
This activity is intended for pulmonologists, cardiologists, cardiopulmonary surgeons, rheumatologists and other HCPs involved in the care of patients with CTEPH globally.
Learning objectives
Learning Objectives
- Describe the biological and pathophysiological mechanisms of CTEPH
- Summarize the evolving data supporting the use of oral therapies
- Explain how new developments in medical therapy for the treatment of CTEPH will change daily practice
